Abstract:Objective: In the present work, an attempt has been made to mimic Ezetimibe with the design of flexible linear acetamides bearing amino, oxy, and thio groups in beta position as cholesterol absorption inhibitors. Methods: Compounds ( I–VII ) were prepared and analyzed for cholesterol lowering activity in vivo by determining total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and triglyceride (TG). Results and Discussion: Among the acetamides prepared, compound ( III ) (total cholesterol: 137.5; triglycerides: 93.8; HDL: 55.2; LDL: 81; VLDL: 17.8), and compound ( VI ) (total cholesterol: 134.1; triglycerides: 92.3; HDL: 51.8; LDL: 76.5; VLDL: 17.3) showed excellent in vivo cholesterol lowering activity when compared to all other compounds and even better activity than the standard drug atorvastatin (total cholesterol: 141.7; triglycerides: 95.3; HDL: 57.5; LDL: 83.2; VLDL: 19.5). As a reflection of the cholesterol lowering activities, Wistar albino rats treated with ( III ) and ( VI ) showed a maximum decrease in their body weights, 260.4 and 256.3 g respectively, when compared to all other prepared compounds as well as the standard drug (270.7 g). All the synthesized compounds along with the Ezetimibe were docked with the target enzyme Niemann-Pick C1-like1 (NPC1L1) protein (PDB ID: 3QNT), performed by AutoDock 4.0 tool. Conclusions: The molecular docking analysis demonstrated that ( III ) –4.92 kcal/mol and ( VI ) –5.36 kcal/mol achieved the highest binding affinity scores with good hydrogen bonds and hydrophobic interactions, all contributed to the stabilization of the compounds at the protein's target site.

A Convenient Synthesis of Ezetimibe Analogs As Cholesterol Absorption Inhibitors

Synthesis and Biological Evaluation of Ezetimibe Analogs As Possible Cholesterol Absorption Inhibitors.

Ezetimibe Analogs with a Reorganized Azetidinone Ring: Design, Synthesis, and Evaluation of Cholesterol Absorption Inhibitions.

New Synthesis Process for the Synthesis of Ezetimibe

4-Cf3-ezetimibe Analogs: Design, Synthesis, and Biological Evaluation of Cholesterol Absorption Inhibitions

Synthesis and Biological Evaluation of 2-Azetidinone Derivatives As Cholesterol Absorption Inhibitors

Synthesis and Bioactivities of 2-Azetidinones As Cholesterol Absorption Inhibitors

Discovery, Synthesis and Evaluation of Novel Cholesterol Absorption Inhibitors

Efficient and Scalable Process for the Synthesis of Antihypercholesterolemic Drug Ezetimibe

Ezetimibe, a Novel Selective Cholesterol Absorption Inhibitor

Design and Synthesis of 2-Azetidinone Cholesterol Absorption Inhibitors

2-Azetidinone Derivatives: Design, Synthesis and Evaluation of Cholesterol Absorption Inhibitors

Design, Synthesis and Biological Evaluation of N,N-3-phenyl-3-benzylaminopropanamide Derivatives As Novel Cholesteryl Ester Transfer Protein Inhibitor

First Synthesis and Characterization of Srr/Rss-Ezetimibe

New azetidinone cholesterol absorption inhibitors

Merger of Ezetimibe and Statin: A Potential Dual Inhibitor

Synthesis of a New Antihyperlipidaemic Agent-Simvastatin

Design and Synthesis of Linear Acetamides as Cholesterol Lowering Agents

Synthesis and Characterization of Ezetimibe Pharmaceutical Cocrystal: A Reaction Crystallization Method to Improve Physicochemical Properties and Hypolipemic Activity Evaluation

Virtual Screening for Cholesterol Absorption Inhibitors.

Ezetimibe: Its Novel Effects on the Prevention and the Treatment of Cholesterol Gallstones and Nonalcoholic Fatty Liver Disease